Ascend Wellness Holdings (AAWH) EPS (Basic) Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ascend Wellness Holdings | 97.42 Mn | 30.42 Mn | 45.49 Mn | 59.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.54% |
| Mar 31, 2026 | -55.07% |
| Dec 31, 2025 | -202.82% |
| Sep 30, 2025 | 3.51% |
| Jun 30, 2025 | -17.15% |
| Mar 31, 2025 | -8.08% |
| Dec 31, 2024 | 18.62% |
| Sep 30, 2024 | -141.32% |
| Jun 30, 2024 | -2,477.47% |
| Mar 31, 2024 | 11.30% |
| Dec 31, 2023 | -18.35% |
| Sep 30, 2023 | 39.18% |
| Jun 30, 2023 | 103.76% |
| Mar 31, 2023 | 39.22% |
| Dec 31, 2022 | 25.72% |
| Sep 30, 2022 | -17.16% |
| Jun 30, 2022 | 61.74% |
| Mar 31, 2022 | 64.41% |
| Dec 31, 2021 | -40.14% |
| Sep 30, 2021 | -50.57% |